Revolutionary technology for cell handling receives continued support from Sten K Johnson

 

Lund, Sweden – Deep Tech company Sorbus Biomedical, a member of SmiLe Incubator in Lund, has been awarded a grant by the Sten K Johnson Foundation for its project “Evaluation of prototype equipment for expansive culturing of clinically relevant cells.” The grant will provide new opportunities to test the company’s innovative equipment, which by restoring the natural environment of the cells makes it possible to produce and work with healthier and more valuable cells.

 

Traditional equipment for culturing and handling cells in the laboratory environment stress the cells, which lose their usefulness as they are exposed to circumstances that differ in a harmful way from their natural environment inside the body.

 

“There is a great unmet need in academia, the pharmaceutical industry and the clinical setting to be able to grow cells that are more functionally appropriate than those that can be cultured today in order to achieve greater efficiency and potential new uses. With Sorbus Biomedical’s new disruptive technology, we hope to revolutionize how cells are cultured and used in life science. Thanks to the generous support from Sten K Johnson we can now take one step closer to our goal,” says Roger Rönn, founder and CEO of Sorbus Biomedical.

 

The company’s innovative technology is relevant anywhere that cells are used, such as in analysis, or for culturing (production) cells for a variety of applications in the life sciences.

 

“I’m thrilled and grateful that the Sten K Johnson Foundation has once again shown support and confidence in the company's operations. Thanks to this grant, Sorbus Biomedical can evaluate its technology with clinically relevant cells and thus take an important step forward in its product development. It is both amazing and exciting,” says Roger Rönn.

 

 

For more information, please contact: Roger Rönn, +46 (0)73 536 6181, roger.ronn@sorbusbiomedical.se

---

---